The Swiss government says it has struck a deal with Moderna to supply Switzerland with 4.5 million doses of a COVID-19 vaccine if the U.S. biotech firm successfully develops one
Moderna (MRNA) soared a further 16% in Tuesday’s after-market trading after the biotech announced the publication of an interim analysis of the open-label Phase 1 study of mRNA-1273, its vaccine candidate against COVID-19.Results reaffirmed positive interim data assessment announced on May 18, said Moderna, and show mRNA-1273 induced rapid and strong immune […]
Results from the phase 1 clinical trial of Moderna’s coronavirus vaccine show it’s on the right track, though there were serious side effects at high doses.
Foreaders 